GoHealth, Inc. (GOCO): Nasdaq/NYSE listing notice — GoHealth receives Nasdaq delisting notice after Chapter 11 filing; trading suspended June 16

GoHealth, Inc.

Nasdaq delisting based on Chapter 11 filing, public interest concerns, and residual equity holder issues.
Trading of GOCO suspended at opening of business on June 16, 2026; Form 25-NSE to follow.
Company will not appeal the delisting determination.
Shares expected to trade on OTC markets, but liquidity will be significantly reduced.
Prior deficiency: Company failed to meet minimum $35M market value requirement since March 18, 2026.

item 3.01

Featured in Daily 8-K Digest

Selected #9 for 2026-06-11. Read digest

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

GoHealth, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1, 5550(b)(2)).

Exchange: nasdaq
Notice: delisting notice
Rules: 5101, 5110(b), IM-5101-1, 5550(b)(2)

Exact text from the filing

June 9, 2026, the Company received a written notice (the “Nasdaq Notice”) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, pursuant to Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, Nasdaq has determined to delist the Company’s Class A common stock (Nasdaq: GOCO) from Nasdaq. Pursuant to the Nasdaq Notice, Nasdaq’s determination was based on (i) the filing of the Chapter 11 Cases and associated public interest concerns raised thereby, (ii) concerns regarding the residual equity interest of existing listed securities holders and (iii

View on SEC.gov

92 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

GoHealth, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-042509

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.